期刊文献+

人源CD137L基因在不同表达系统中表达效率的比较 被引量:1

The Comparison of Expression Efficiency of Human CD137L in Different Expression System
下载PDF
导出
摘要 比较分析人源CD137L在毕赤酵母、枯草杆菌及大肠杆菌中的表达差异,建立适合CD137L的表达系统并检测CD137L的生物学活性。设计PCR引物,以酵母表达质粒pPIC9K-CD137L为模板,扩增CD137L片段,分别构建枯草杆菌表达质粒及大肠杆菌表达质粒,再转化至相应的宿主菌并筛选阳性转化子;SDS PAGE电泳分析CD137L的表达情况并比较差异;稀释复性法复性CD137L包涵体,用离子交换层析纯化CD137L;T细胞激活试验检测CD137L的活性。CD137L在3个表达系统中均可以表达并且得到质谱鉴定,但是在毕赤酵母、枯草杆菌中的表达量微弱,而在大肠杆菌中CD137L以包涵体形式高效表达,平均1 L培养液能得到0.8 g包涵体沉淀,200 mg变性蛋白。经复性纯化后得到的CD137L能有效激活T细胞增殖并且其刺激活性呈现浓度依赖效应。与毕赤酵母、枯草杆菌相比,大肠杆菌表达系统能高效表达CD137L蛋白,并且经稀释复性后CD137L保持了刺激小鼠T细胞增殖的活性。 It was to construct a suitable expression system for CD137 L by comparison of expression level of CD137 L in Pichia yeast, Bacillus subtilis, and Escherichia coli and determine the effect of CD137 L on T cell proliferation. CD137 L was amplified by PCR with designed primers from yeast expression plasmid pPIC9K-CD137 L and subcloned into vector pP43 or pET11 a. Then recombinant plasmid pPIC9KCD137 L, pP43-CD137 L and pET11a-CD137 L were transformed into GS115, WB800 and BL21, respectively. Positive clones were screened and expression of CD137 L was detected by SDS-PAGE. Then inclusion body of CD137 L from Escherichia coli was refolded by dilute refolding and CD137 L was purified by ion exchange chromatography. After that, bioactivity of CD137 L was determined by T cell proliferation assay. CD137 L was expressed by all the three expression system and further confirmed by Western blot assay. But expression level of CD137 L in GS115 and WB800 was too weak for further study. In contrast, CD137 L was efficiently expressed in BL21 as inclusion body. It was about 0.8 g inclusion body per 1 L cultured BL21 and 200 mg denatured protein was obtained. Then inclusion body was dissolved in 8 mol/L urea at 50℃or 60℃, and active protein CD137 L was obtained after dilute refolding. Then refolded CD137 L was purified by ion exchange chromatography, and purified CD137 L demonstrated significantly costimulatory effect on T cell proliferation in dose-dependent manner. It was demonstrated that CD137 L was efficiently expressed in Escherichia coli expression system compared with Pichia yeast and Bacillus subtilis, and purified CD137 L kept costimulatory activity on T cell proliferation.
出处 《生物技术通报》 CAS CSCD 北大核心 2014年第9期178-183,共6页 Biotechnology Bulletin
基金 天然药物活性组分与药效国家重点实验室(中国药科大学)资助项目(JKGQ201105)
关键词 毕赤酵母 枯草杆菌 大肠杆菌 CD137L T细胞增殖 Pichia pastoris Bacillus subtilis Escherichia coli CD137L T cell proliferation
  • 相关文献

参考文献23

  • 1Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation [J]. Cell, 2011, 144 (5): 646-674.
  • 2Couzin-Frankel J. Breakthrough of the year 2013. Cancer Immunotherapy [J]. Science, 2013, 342 (6165): 1432-1433.
  • 3Podojil JR, Miller SD. Molecular mechanisms of T-cell receptor and costimulatory molecule ligation/hlockade in autoimmune disease therapy [J]. Immunol Rev, 2009, 229 (1): 337-355.
  • 4Meseck M, Huang T, Ma G, et al. A functional recomhinant human 4-lBB ligand for immune costimulatory therapy of cancer [J]. J Immunother, 2011, 34 (2): 175-182.
  • 5Wang S, Lv J, Wang P, et al. Recombinant human CD137L for cancer immunotherapy : effects of different fusions and linkers on its activity [J]. Cancer Immunol Immunother, 2012, 61 (4): 489- 495.
  • 6Alderson MR, Smith CA, Tough TW, et al. Molecular and hiological characterization of human 4-1 BB and its ligand [J]. Eur J Immunol, 1994,24 (9): 2219-2227.
  • 7Palma C, Binaschi M, Bigioni M, et al. CD137 and CD137 ligand constitutively coexpressed on human T and B leukemia cells signal proliferation and survival [J]. Int J Cancer, 2004, 108 (3): 390- 398.
  • 8Palazon A, Teijeira A, Martinez-Forero I, et al. Agonist anti-CD137 mAb act on tumor endothelial cells to enhance recruitment of activated T lymphocytes [J]. Cancer Res, 2011, 71 (3): 801- 811.
  • 9Wilcox RA, Flies DB, Zhu G, et al. Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors [J] . J Clin Invest, 2002, 109 (5): 651-659.
  • 10DeBenedette MA, Wen T, Bachmann MF, et al. Analysis of 4-IBB ligand (4-IBBL)-deficient mice and of mice lacking botb 4-IBBL and CD28 reveals a role for 4-IBBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus [J]. J Immunol, 1999,163 (9): 4833-4841.

二级参考文献69

  • 1Arthur I Cederbaum.Hepatoprotective effects of S-adenosyl-L-methionine against alcohol-and cytochrome P450 2E1-induced liver injury[J].World Journal of Gastroenterology,2010,16(11):1366-1376. 被引量:24
  • 2周薇,羊语梅,张军岷.品红—亚硫酸比色法测定酒中甲醇的方法改进[J].中国卫生检验杂志,2004,14(5):647-647. 被引量:10
  • 3邢良英,王远山,郑裕国.葡萄糖氧化酶的生产及应用[J].食品科技,2007,32(6):24-26. 被引量:17
  • 4汪家政 范明.蛋白质技术手册[M].北京:科学出版社,2002.77-97.
  • 5Spizizen J. Transformation of biochemically deficient strains of Bacillus subtilis by deoxyribonucleate. Proc Natl Acad Sei USA, 1958, 44:1072
  • 6Losick R and Pero J. Cascades of sigma factors. Cell, 1981, 25: 582.
  • 7Doi RH. Multiple RNA polymerase holoenzymes exert transcriptional specificity in Bacillus subtilis. Archives of Biochemistry and Biophysics,1982, 214:772
  • 8Moran CP, Jr Lang N, Legrice SFJ et al. Nucleotide sequences that signal the initiation of transcription and translation in Bacillus subtilis.Mol Gen Genetics, 1982, 186:339
  • 9Doi RH. Genetic engineering in Bacillus .ubtilis. Biotechnol Genet Eng Rey, 1984, 2:121
  • 10Banner CDB, Moran CP, Jr Losick R. Deletion analysis of a complex promoter for a development-ally regulated gene from Bacillus subtilis. J Mol Biol, 1983, 168:351

共引文献30

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部